Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals

Christine M Bassis, John R Erb-Downward, Robert P Dickson, Christine M Freeman, Thomas M Schmidt, Vincent B Young, James M Beck, Jeffrey L Curtis, Gary B Huffnagle, Christine M Bassis, John R Erb-Downward, Robert P Dickson, Christine M Freeman, Thomas M Schmidt, Vincent B Young, James M Beck, Jeffrey L Curtis, Gary B Huffnagle

Abstract

No studies have examined the relationships between bacterial communities along sites of the upper aerodigestive tract of an individual subject. Our objective was to perform an intrasubject and intersite analysis to determine the contributions of two upper mucosal sites (mouth and nose) as source communities for the bacterial microbiome of lower sites (lungs and stomach). Oral wash, bronchoalveolar lavage (BAL) fluid, nasal swab, and gastric aspirate samples were collected from 28 healthy subjects. Extensive analysis of controls and serial intrasubject BAL fluid samples demonstrated that sampling of the lungs by bronchoscopy was not confounded by oral microbiome contamination. By quantitative PCR, the oral cavity and stomach contained the highest bacterial signal levels and the nasal cavity and lungs contained much lower levels. Pyrosequencing of 16S rRNA gene amplicon libraries generated from these samples showed that the oral and gastric compartments had the greatest species richness, which was significantly greater in both than the richness measured in the lungs and nasal cavity. The bacterial communities of the lungs were significantly different from those of the mouth, nose, and stomach, while the greatest similarity was between the oral and gastric communities. However, the bacterial communities of healthy lungs shared significant membership with the mouth, but not the nose, and marked subject-subject variation was noted. In summary, microbial immigration from the oral cavity appears to be the significant source of the lung microbiome during health, but unlike the stomach, the lungs exhibit evidence of selective elimination of Prevotella bacteria derived from the upper airways.

Importance: We have demonstrated that the bacterial communities of the healthy lung overlapped those found in the mouth but were found at lower concentrations, with lower membership and a different community composition. The nasal microbiome, which was distinct from the oral microbiome, appeared to contribute little to the composition of the lung microbiome in healthy subjects. Our studies of the nasal, oral, lung, and stomach microbiomes within an individual illustrate the microbiological continuity of the aerodigestive tract in healthy adults and provide culture-independent microbiological support for the concept that microaspiration is common in healthy individuals.

Copyright © 2015 Bassis et al.

Figures

FIG 1
FIG 1
The aerodigestive tract. Schematic of the flow relationship between the oral and nasal cavities and the lungs and stomach. The numbers indicate the five sites sampled in this study.
FIG 2
FIG 2
(A) Intrasubject similarity indices (θYC distance [1 − θYC]) between the bacterial communities of the first return BAL fluid (BAL1) and oral wash samples, compared to the second return BAL fluid (BAL2) and oral wash samples from that same subject. Distances were based on a 3% OTU definition with subsampling of 700 sequences/sample. There was no statistically significant difference in the oral-BAL fluid sample comparison of the first and second return BAL fluid samples in terms of bacterial community composition. (B) 16S rRNA gene qPCR of DNA prepared from the samples in this study, as well as bronchoscope rinse saline and prebronchoscope saline. The number of copies of bacterial 16S rRNA genes per 5 ml of sample (saline, scope, BAL, oral, and gastric) or per (nasal) swab was measured by qPCR as described in Materials and Methods. Sample groups were compared by ANOVA and Tukey’s multiple-comparison test. Data are the mean ± the standard error of the mean. *, P < 0.05 compared to saline only; other significant comparisons are shown in the graph; nd, not done (because the swab was of a different sample type). (C) Bacterial species richness of each site, as determined by calculating the number of OTUs (97% identity) per sample after subsampling of all samples to the same depth of 700 reads. Sample groups were compared by ANOVA and Tukey’s multiple-comparison test.
FIG 3
FIG 3
(A, B) Graphic representation of the results of an RDA of the bacterial samples isolated from each of the four sites to determine whether a significant amount of the variation can be explained by differences in sample location. (A) Comparison of nasal, oral, and lung samples in RDA1 versus RDA2. (B) Comparison of nasal, oral, and gastric samples on RDA1 versus RDA2. (C) Indices of intrasubject similarity (θYC distance [1 − θYC]) between the bacterial communities of the two source sites (mouth and nose) and two target sites (lungs and stomach) of that subject. As shown, shorter θYC distances correspond to greater similarities between the bacterial communities of the samples indicated. Distances were based on a 3% OTU definition with subsampling of 700 sequences/sample.
FIG 4
FIG 4
Rank abundance plots for each of the sampling locations based on the top 50 OTUs from the overall order (greatest to smallest) taken from all of the samples combined. The bars depict the mean ± the standard error of the mean. Bars are colored according to their phyla. The family, genus, and OTU identification of the bacterial community members are displayed along the x axis of panel D.
FIG 5
FIG 5
Paired analysis of Prevotella abundance distribution in the oral wash of an individual and the abundance of that same OTU in the gastric aspirate (A) and BAL fluid (B) of the same individual. Prevotella OTUs were determined as described in Materials and Methods, and all of the samples from all of the sites were subsampled to 700 reads. For this analysis, any OTU below the limit of detection was assigned an abundance of 0.07%. The solid line indicates a 1:1 ratio of abundance in the oral wash compared to the gastric aspirate (A) or BAL fluid (B), and the dotted lines are 2:1 and 1:2 ratios. Six Prevotella OTUs were detected in the analysis, and the abundance of each OTU in each of the 28 subjects is displayed on the graphs (168 data points/graph). The oral-BAL fluid sample and oral-gastric sample data sets were significantly different from each other (P = 0.003). The mean ratio within the oral-gastric sample data set was 1.18:1, while the mean ratio within the oral-BAL fluid sample data set was 2.04:1. Other abundance comparisons: 11.4% of the observations in the oral-BAL fluid sample data set were at a ratio of 64:1 or greater, and 31.0% were at 8:1 or higher, while only 2.4% of the observations in the oral-gastric sample data set were 64:1 or greater and only 14.3% were 8:1 or greater.

References

    1. Dickson RP, Erb-Downward JR, Huffnagle GB. 2013. The role of the bacterial microbiome in lung disease. Expert Rev Respir Med 7:245–257. doi:10.1586/ers.13.24.
    1. Dickson RP, Erb-Downward JR, Huffnagle GB. 2014. Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir. Med. 2:238–246. doi:10.1016/S2213-2600(14)70028-1.
    1. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, Moffatt MF, Cookson WO. 2010. Disordered microbial communities in asthmatic airways. PLoS One 5:e8578. doi:10.1371/journal.pone.0008578.
    1. Huang YJ, Lynch SV. 2011. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med 5:809-821. doi:10.1586/ers.11.76.
    1. Human Microbiome Project Consortium 2012. Structure, function and diversity of the healthy human microbiome. Nature 486:207–214. doi:10.1038/nature11234.
    1. Gleeson K, Eggli DF, Maxwell SL. 1997. Quantitative aspiration during sleep in normal subjects. Chest 111:1266–1272. doi:10.1378/chest.111.5.1266.
    1. Huxley EJ, Viroslav J, Gray WR, Pierce AK. 1978. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 64:564–568. doi:10.1016/0002-9343(78)90574-0.
    1. Quinn LH, Meyer OO. 1929. The relationship of sinusitis and bronchiectasis. Arch. Otolaryngol Head Neck Surg 10:152–165. doi:10.1001/archotol.1929.00620050048003.
    1. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG. 2011. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 184:957–963. doi:10.1164/rccm.201104-0655OC.
    1. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB. 2011. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One 6:e16384. doi:10.1371/journal.pone.0016384.
    1. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J, Wiener-Kronish JP, Sutherland ER, King TS, Icitovic N, Martin RJ, Calhoun WJ, Castro M, Denlinger LC, Dimango E, Kraft M, Peters SP, Wasserman SI, Wechsler ME, Boushey HA, Lynch SV. 2011. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 127:372–381.e1-3. doi:10.1016/j.jaci.2010.10.048.
    1. Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. 2012. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 7:e47305. doi:10.1371/journal.pone.0047305.
    1. Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Chen H, Berger KI, Goldring RM, Rom WN, Blaser MJ, Weiden MD. 2013. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 1:19. doi:10.1186/2049-2618-1-19.
    1. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, Cooper J, Sin DD, Mohn WW, Hogg JC. 2012. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185:1073–1080. doi:10.1164/rccm.201111-2075OC.
    1. Dickson RP, Martinez FJ, Huffnagle GB. 2014. The role of the microbiome in exacerbations of chronic lung diseases. Lancet 384:691–702. doi:10.1016/S0140-6736(14)61136-3.
    1. Dickson RP, Erb-Downward JR, Freeman CM, Walker N, Scales BS, Beck JM, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB. 2014. Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PLoS One 9:e97214. doi:10.1371/journal.pone.0097214.
    1. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, Flores SC, Fontenot AP, Ghedin E, Huang L, Jablonski K, Kleerup E, Lynch SV, Sodergren E, Twigg H, Young VB, Bassis CM, Venkataraman A, Schmidt TM, Weinstock GM. 2013. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med 187:1067–1075. doi:10.1164/rccm.201210-1913OC.
    1. Yang I, Nell S, Suerbaum S. 2013. Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol Rev 37:736–761. doi:10.1111/1574-6976.12027.
    1. Delgado S, Cabrera-Rubio R, Mira A, Suárez A, Mayo B. 2013. Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microb Ecol 65:763–772. doi:10.1007/s00248-013-0192-5.
    1. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. 2006. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 103:732–737. doi:10.1073/pnas.0506655103.
    1. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA, NISC Comparative Sequencing Program . 2009. Topographical and temporal diversity of the human skin microbiome. Science 324:1190–1192. doi:10.1126/science.1171700.
    1. Charlson ES, Chen J, Custers-Allen R, Bittinger K, Li H, Sinha R, Hwang J, Bushman FD, Collman RG. 2010. Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One 5:e15216. doi:10.1371/journal.pone.0015216.
    1. Rasmussen TT, Kirkeby LP, Poulsen K, Reinholdt J, Kilian M. 2000. Resident aerobic microbiota of the adult human nasal cavity. APMIS 108:663–675. doi:10.1034/j.1600-0463.2000.d01-13.x.
    1. Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WOC, Moffatt MF, Johnston SL. 2013. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 188: 1224–1231. doi:10.1164/rccm.201302-0341OC.
    1. Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, Wiener-Kronish JP, Lynch SV. 2010. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. Omics 14:9–59. doi:10.1089/omi.2009.0100.
    1. Sadighi Akha AA, Theriot CM, Erb-Downward JR, McDermott AJ, Falkowski NR, Tyra HM, Rutkowski DT, Young VB, Huffnagle GB. 2013. Acute infection of mice with Clostridium difficile leads to eIF2alpha phosphorylation and pro-survival signalling as part of the mucosal inflammatory response. Immunology 140:111–122. doi:10.1111/imm.12122.
    1. Dickson RP, Erb-Downward JR, Prescott HC, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB. 2014. Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol 52:3605–3613. doi:10.1128/JCM.01028-14.
    1. Bertolini V, Gandolfi I, Ambrosini R, Bestetti G, Innocente E, Rampazzo G, Franzetti A. 2013. Temporal variability and effect of environmental variables on airborne bacterial communities in an urban area of northern Italy. Appl Microbiol Biotechnol 97:6561–6570. doi:10.1007/s00253-012-4450-0.
    1. Bowers RM, McLetchie S, Knight R, Fierer N. 2011. Spatial variability in airborne bacterial communities across land-use types and their relationship to the bacterial communities of potential source environments. ISME J 5:601–612. doi:10.1038/ismej.2010.167.
    1. Bowers RM, Sullivan AP, Costello EK, Collett JL Jr., Knight R, Fierer N. 2011. Sources of bacteria in outdoor air across cities in the midwestern United States. Appl Environ Microbiol 77:6350–6356. doi:10.1128/AEM.05498-11.
    1. Fierer N, Liu Z, Rodríguez-Hernández M, Knight R, Henn M, Hernandez MT. 2008. Short-term temporal variability in airborne bacterial and fungal populations. Appl Environ Microbiol 74:200–207. doi:10.1128/AEM.01467-07.
    1. Munyard P, Bush A. 1996. How much coughing is normal? Arch Dis Child 74:531–534. doi:10.1136/adc.74.6.531.
    1. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, Kim KS, McCormack FX. 2003. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 111:1589–1602. doi:10.1172/JCI16889.
    1. Larsen JM, Musavian HS, Butt TM, Ingvorsen C, Thysen AH, Brix S. 2015. COPD and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote TLR2-independent lung inflammation and pathology. Immunology 144:333–342. doi:10.1111/imm.12376.
    1. Larsen JM, Steen-Jensen DB, Laursen JM, Søndergaard JN, Musavian HS, Butt TM, Brix S. 2012. Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One 7:e31976. doi:10.1371/journal.pone.0031976.
    1. Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ, Bushman FD, Artis D. 2010. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 3:148–158. doi:10.1038/mi.2009.132.
    1. Bassis CM, Tang AL, Young VB, Pynnonen MA. 2014. The nasal cavity microbiota of healthy adults. Microbiome 2:27. doi:10.1186/2049-2618-2-27.
    1. Bassis CM, Theriot CM, Young VB. 2014. Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection. Antimicrob Agents Chemother 58:2767–2774. doi:10.1128/AAC.02262-13.
    1. Schloss PD, Gevers D, Westcott SL. 2011. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One 6:e27310. doi:10.1371/journal.pone.0027310.
    1. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537–7541. doi:10.1128/AEM.01541-09.
    1. Hashway SA, Bergin IL, Bassis CM, Uchihashi M, Schmidt KC, Young VB, Aronoff DM, Patton DL, Bell JD. 2014. Impact of a hormone-releasing intrauterine system on the vaginal microbiome: a prospective baboon model. J Med Primatol 43:89–99. doi:10.1111/jmp.12090.
    1. Sloan WT, Lunn M, Woodcock S, Head IM, Nee S, Curtis TP. 2006. Quantifying the roles of immigration and chance in shaping prokaryote community structure. Environ Microbiol 8:732–740. doi:10.1111/j.1462-2920.2005.00956.x.
    1. Anderson MJ. 2001. A new method for non-parametric multivariate analysis of variance. Austral Ecol 26:32–46. .
    1. Yue JC, Clayton MK. 2005. A similarity measure based on species proportions. Commun Stat Theory Methods 34:2123–2131. doi:10.1080/STA-200066418.

Source: PubMed

3
Abonnere